Cargando…

Aberrant E-cadherin staining patterns in invasive mammary carcinoma

BACKGROUND: E-cadherin, a cell surface protein involved in cell adhesion, is present in normal breast epithelium, benign breast lesions, and in breast carcinoma. Alterations in the gene CDH1 on chromosome 16q22 are associated with changes in E-cadherin protein expression and function. Inactivation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Harigopal, Malini, Shin, Sandra J, Murray, Melissa P, Tickoo, Satish K, Brogi, Edi, Rosen, Paul Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308872/
https://www.ncbi.nlm.nih.gov/pubmed/16287501
http://dx.doi.org/10.1186/1477-7819-3-73
_version_ 1782126300417228800
author Harigopal, Malini
Shin, Sandra J
Murray, Melissa P
Tickoo, Satish K
Brogi, Edi
Rosen, Paul Peter
author_facet Harigopal, Malini
Shin, Sandra J
Murray, Melissa P
Tickoo, Satish K
Brogi, Edi
Rosen, Paul Peter
author_sort Harigopal, Malini
collection PubMed
description BACKGROUND: E-cadherin, a cell surface protein involved in cell adhesion, is present in normal breast epithelium, benign breast lesions, and in breast carcinoma. Alterations in the gene CDH1 on chromosome 16q22 are associated with changes in E-cadherin protein expression and function. Inactivation of E-cadherin in lobular carcinomas and certain diffuse gastric carcinomas may play a role in the dispersed, discohesive "single cell" growth patterns seen in these tumors. The molecular "signature" of mammary lobular carcinomas is the loss of E-cadherin protein expression as evidenced by immunohistochemistry, whereas ductal carcinomas are typically E-cadherin positive. PATIENTS AND METHODS: We report on E-cadherin immunostaining patterns in five cases of invasive mammary carcinoma RESULTS: These were five exceptional instances in which the E-cadherin immunophenotype did not correspond to the apparent histologic classification of the lesion. These cases which are exceedingly rare in our experience are the subject of this report. CONCLUSION: Findings such as those illustrated in this study occur in virtually all biologic phenomena and they do not invalidate the very high degree of correlation between the expression of E-cadherin and the classification of breast carcinomas as ductal or lobular type on the basis of conventional histologic criteria.
format Text
id pubmed-1308872
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-13088722005-12-08 Aberrant E-cadherin staining patterns in invasive mammary carcinoma Harigopal, Malini Shin, Sandra J Murray, Melissa P Tickoo, Satish K Brogi, Edi Rosen, Paul Peter World J Surg Oncol Research BACKGROUND: E-cadherin, a cell surface protein involved in cell adhesion, is present in normal breast epithelium, benign breast lesions, and in breast carcinoma. Alterations in the gene CDH1 on chromosome 16q22 are associated with changes in E-cadherin protein expression and function. Inactivation of E-cadherin in lobular carcinomas and certain diffuse gastric carcinomas may play a role in the dispersed, discohesive "single cell" growth patterns seen in these tumors. The molecular "signature" of mammary lobular carcinomas is the loss of E-cadherin protein expression as evidenced by immunohistochemistry, whereas ductal carcinomas are typically E-cadherin positive. PATIENTS AND METHODS: We report on E-cadherin immunostaining patterns in five cases of invasive mammary carcinoma RESULTS: These were five exceptional instances in which the E-cadherin immunophenotype did not correspond to the apparent histologic classification of the lesion. These cases which are exceedingly rare in our experience are the subject of this report. CONCLUSION: Findings such as those illustrated in this study occur in virtually all biologic phenomena and they do not invalidate the very high degree of correlation between the expression of E-cadherin and the classification of breast carcinomas as ductal or lobular type on the basis of conventional histologic criteria. BioMed Central 2005-11-14 /pmc/articles/PMC1308872/ /pubmed/16287501 http://dx.doi.org/10.1186/1477-7819-3-73 Text en Copyright © 2005 Harigopal et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Harigopal, Malini
Shin, Sandra J
Murray, Melissa P
Tickoo, Satish K
Brogi, Edi
Rosen, Paul Peter
Aberrant E-cadherin staining patterns in invasive mammary carcinoma
title Aberrant E-cadherin staining patterns in invasive mammary carcinoma
title_full Aberrant E-cadherin staining patterns in invasive mammary carcinoma
title_fullStr Aberrant E-cadherin staining patterns in invasive mammary carcinoma
title_full_unstemmed Aberrant E-cadherin staining patterns in invasive mammary carcinoma
title_short Aberrant E-cadherin staining patterns in invasive mammary carcinoma
title_sort aberrant e-cadherin staining patterns in invasive mammary carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308872/
https://www.ncbi.nlm.nih.gov/pubmed/16287501
http://dx.doi.org/10.1186/1477-7819-3-73
work_keys_str_mv AT harigopalmalini aberrantecadherinstainingpatternsininvasivemammarycarcinoma
AT shinsandraj aberrantecadherinstainingpatternsininvasivemammarycarcinoma
AT murraymelissap aberrantecadherinstainingpatternsininvasivemammarycarcinoma
AT tickoosatishk aberrantecadherinstainingpatternsininvasivemammarycarcinoma
AT brogiedi aberrantecadherinstainingpatternsininvasivemammarycarcinoma
AT rosenpaulpeter aberrantecadherinstainingpatternsininvasivemammarycarcinoma